High-fidelity optical platform for multiplex glutathione profiling links redox dynamics to tumor progression and auxiliary diagnosis
Biosensors and Bioelectronics · 2025
DOI: 10.1016/j.bios.2025.117705 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2025. Verfasst von Weizhen Yan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China; National Clinical Research Center for Geriatric D…. Hauptthemen laut MEDLINE: Glutathione, Biosensing Techniques, Stomach Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: Hunan Provincial Natural Science Foundation, Science and Technology Program of Hunan Province, Wu Jieping Medical Foundation.
Abstract (Originalsprache)
Gastric cancer, a leading global cause of tumor-related mortality, demands potent biomarkers and robust analytical technologies to reduce the clinical burden. Here, a dual-mode ratiometric optical sensor paired with a portable smartphone-based reader was developed for glutathione (GSH). This work reveals, for the first time, the molecular mechanism behind the responsibility and selectivity of tetraphenylporphyrin tetrasulfonic acid (TPPS) to GSH. This high-fidelity character eliminates cross-interference from competing thiols and mitigates the inherent susceptibility of TPPS to transition metals by strategic masking agents. The sensor exhibits a dose-sensitive response to GSH from 0 to 200 μM with a limit of detection (LOD) of 0.75 μM. Following validation with pharmaceutical samples and cellular assays, the platform was translated into clinical research for tumor progression and auxiliary diagnosis. By cohorts of gastric cancer and health control, a multivariate model linking clinical signatures with GSH levels was established, which reveals significant correlations between GSH and tumor size, tumor infiltration, and nutritional status. Further developed diagnostic model combining GSH and pepsinogen II (PGII) yielded an area under the curve (AUC) of 0.986 for distinguishing cancer patients from healthy controls. These studies highlight applicability of GSH-based optical sensing in precision oncology for clinical management of gastric cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan,…
Förderung
- Hunan Provincial Natural Science Foundation
- Science and Technology Program of Hunan Province
- Wu Jieping Medical Foundation
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Yan, W., Han, Y., Zhu, J., Gao, Y., Zhang, P., Gou, Y., Xiao, Y., Fei, J., Zou, X., Liu, Y., Huang, K., Shen, H., Zeng, S., Chen, Y., & Cai, C. (2025). High-fidelity optical platform for multiplex glutathione profiling links redox dynamics to tumor progression and auxiliary diagnosis. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2025.117705
Vancouver
Yan W, Han Y, Zhu J, Gao Y, Zhang P, Gou Y, et al. High-fidelity optical platform for multiplex glutathione profiling links redox dynamics to tumor progression and auxiliary diagnosis. Biosensors and Bioelectronics. 2025. doi:10.1016/j.bios.2025.117705
BibTeX
@article{Yan2025,
author = {Yan, Weizhen and Han, Ying and Zhu, Jiang and Gao, Yan and Zhang, Peng and Gou, Yue and Xiao, Yu and Fei, Jiang and Zou, Xi and Liu, Yifan and Huang, Kun and Shen, Hong and Zeng, Shan and Chen, Yihong and Cai, Changjing},
title = {High-fidelity optical platform for multiplex glutathione profiling links redox dynamics to tumor progression and auxiliary diagnosis},
journal = {Biosensors and Bioelectronics},
year = {2025},
doi = {10.1016/j.bios.2025.117705}
}
EUVIMED